P9: Distribution of genetic polymorphisms associated to hepatitis C virus (HCV) antiviral response in a multiethnic and admixed population

Abstract

were 100%, 100% and 98.6%. The five patients were relapsed, 80% of relapses were occcured on 12th weeek, 15.4% in 1b and 3% in 2a or 2c. CONCLUSIONS: Most earlier studies have demonstrated, in Genotype 1b, the efficacy of eradication is poor than genotype non 1. But the virologic response is effective in any group of chronic hepatitis C infection by pegylated interferon and ribavirin combination therapy in our study. So, we think that more aggressive treatment is needed in any genotype of chronic hepatitis C and the standard regimen of pegylated interferon and ribavirin combination therapy can be effective in Korean chronic hepatitis C patients.